Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
DHS Working Papers No. 119
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent... the present pipeline addresses infections caused by WHO Priority Pathogens, Mycobacterium tuberculosis and Clostridioides difficile. The report also provides an assessment of the traditional agents with respect to whether they meet a set of predefined criteria for innovation, namely absence of known cross-resistance, new target, mode of action and/or class. It also includes an overview of the agents that obtained authorization since 1 July 2017.
more
Pharmaceutical profile of DRC
DHS Further Analysis Reports No. 108 - This report examines levels, trends, and inequalities in maternal health in Rwanda from 2010 to 2014-15 among women age 15-49 with a recent birth. The analysis uses Demographic and Health Survey (DHS) data for 15 key indicators of maternal health: 6 for antenat...al care, 3 for delivery, 1 for postnatal care, and 5 for barriers to accessing medical care. Levels and trends in these indicators were analyzed overall and by three background characteristics: women’s education, household wealth quintile, and region.
more
DHS Further Analysis Reports No. 97
La publicación evalúa en forma cuantitativa y cualitativa el costo socioeconómico de la tuberculosis en el Perú con la finalidad de mejorar la comprensión real de gasto social y costo que representa para las personas, familias y Estado peruano. Asimismo, desarrolla bajo el marco del Objetivo 4 ...del programa “Haciendo la diferencia: Consolidando una respuesta integral contra la tuberculosis en el Perú.
more
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...terns and distributions of new and longstanding HIV infections.
This technical guidance outlines best practices regarding the appropriate use of HIV recency assays for surveillance purposes and updates 2011 technical guidance from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) on the use of HIV recency assays.
more
DHS Working Papers No. 124
Further Analysis of the 2000, 2005, 2010, and 2014 Cambodia Demographic and Health Surveys | DHS Further Analysis Reports No. 106
DHS WORKING PAPERS 2016 No. 126 | DEMOGRAPHIC AND HEALTH SURVEYS